Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)
China · Delayed Price · Currency is CNY 11.08
-0.17 (-1.51%)
Apr 9, 2026, 3:04 PM CST
SHE:002728 Revenue
In the year 2025, Teyi Pharmaceutical Group Co.,Ltd had annual revenue of 924.53M CNY with 34.42% growth. Teyi Pharmaceutical Group Co.,Ltd had revenue of 232.68M in the quarter ending December 31, 2025, with 0.21% growth.
Revenue
924.53M
Revenue Growth
+34.42%
P/S Ratio
5.99
Revenue / Employee
689.43K
Employees
1,341
Market Cap
5.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 924.53M | 236.74M | 34.42% |
| Dec 31, 2024 | 687.79M | -379.43M | -35.55% |
| Dec 31, 2023 | 1.07B | 180.64M | 20.38% |
| Dec 31, 2022 | 886.57M | 128.41M | 16.94% |
| Jan 1, 2022 | 758.16M | 125.47M | 19.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.63B |
| Jianmin Pharmaceutical Group | 3.37B |
| Luoxin Pharmaceuticals Group Stock | 2.49B |
| Tianjin Lisheng Pharmaceutical | 1.39B |
| Beijing Beilu Pharmaceutical | 1.13B |
| ChengDu ShengNuo Biotec | 741.34M |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 619.88M |
| Nanjing Hicin Pharmaceutical | 615.39M |